The anesthetic method has the potential to allow physicians to keep injuries from evolving into neuropathic pain, a chronic form of pain that arises from flawed signals transmitted to damaged nerves.
The team combined saxitoxin, a powerful local anesthetic, with dexamethasone to prolong saxitoxin’s effects. The two ingredients contain liposomes for nontoxic delivery to the site of nerve or tissue damage.
More Articles on Anesthesia:
Teleflex Receives Initial Clearance for Rusch EZ-Blocker
FDA: Discontinue Use of New England Compounding Center Products to Avoid Meningitis Contamination
Study: Lighter Anesthesia Does Not Improve Mortality Rates for Certain Patients
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
